Search results for "Cutaneous"

showing 10 items of 1022 documents

Zero-contrast percutaneous coronary interventions to preserve kidney function in patients with severe renal impairment and hemodialysis subjects

2019

Introduction Zero-contrast percutaneous coronary intervention (zero-PCI) is a new method for prevention of contrast-induced acute kidney injury (AKI) in patients with chronic kidney disease (CKD). However, evidence for its feasibility, safety and clinical utility is limited to reports of single cases or series of patients. Aim To present outcomes of zero-PCI in patients with severe CKD, including hemodialysis subjects, who were treated with this procedure in order to preserve their renal function. Material and methods Twenty-nine zero-PCIs were performed, mostly as a staged procedure, in 20 patients with advanced CKD. In this group, 4 patients were treated with hemodialysis but presented pr…

medicine.medical_specialtyzero-contrast percutaneous coronary interventionmedicine.medical_treatmentContrast-induced nephropathylcsh:MedicineRenal function030204 cardiovascular system & hematologyRevascularizationurologic and male genital diseasesrenal insufficiency03 medical and health sciences0302 clinical medicine0502 economics and businessmedicineRenal replacement therapyOriginal Paperbusiness.industrylcsh:R05 social sciencesAcute kidney injuryPercutaneous coronary interventionmedicine.diseaseSurgeryacute kidney injurycontrast-induced nephropathy050211 marketingHemodialysisCardiology and Cardiovascular MedicinebusinessKidney diseasePostępy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology
researchProduct

EFFICACY OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION/TRANSCRANIAL DIRECT CURRENT STIMULATION IN COGNITIVE NEUROREHABILITATION

2008

Summary: Cognitive deficits are a common consequence of neurologic disease, in particular, of traumatic brain injury, stroke, and neurodegenerative disorders, and there is evidence that specific cognitive training may be effective in cognitive rehabilitation. Several investigations emphasize the fact that interacting with cortical activity, by means of cortical stimulation, can positively affect the short-term cognitive performance and improve the rehabilitation potential of neurologic patients. In this respect, preliminary evidence suggests that cortical stimulation may play a role in treating aphasia, unilateral neglect, and other cognitive disorders. Several possible mechanisms can accou…

medicine.medical_treatmentBiophysicsLANGUAGE050105 experimental psychologylcsh:RC321-57103 medical and health sciences0302 clinical medicinemedicineHumans0501 psychology and cognitive sciencesCognitive rehabilitation therapylcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeurorehabilitationCerebral CortexRehabilitationTranscranial direct-current stimulationSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaGeneral NeuroscienceTRANSCRANIAL DIRECT CURRENT STIMULATION05 social sciencesMEMORYATTENTIONCognitionCOGNITIVE REHABILITATIONTranscranial Magnetic StimulationCognitive trainingTranscranial magnetic stimulationTreatment OutcomeCOGNITIVE DEFICITSBrain stimulationREPETITIVE TRANSCRANIAL MAGNETIC STIMULATIONTranscutaneous Electric Nerve StimulationNeurology (clinical)PsychologyCognition DisordersNeuroscience030217 neurology & neurosurgery
researchProduct

Comparison of adjuvant and adjuvant-free murine experimental asthma models

2009

Introduction The most widely used protocol for the induction of experimental allergic airway inflammation in mice involves sensitization by intraperitoneal (i.p.) injections of the antigen ovalbumin (OVA) used in conjunction with the adjuvant aluminium hydroxide (alum). Although adjuvants are frequently used, there are questions regarding the necessity of alum for murine asthma studies due to the non-physiological nature of this chemical. Objective The objective of this study was to compare experimental asthma phenotypes between adjuvant and adjuvant-free protocols of murine allergic airway inflammation in an attempt to develop a standardized alternative to adjuvant use. Method An adjuvant-…

medicine.medical_treatmentC57BL/6Aluminum HydroxideintraperitonealMicechemistry.chemical_compoundImmunology and AllergySensitizationMice Inbred BALB CbiologyAluminium hydroxiderespiratory systemPhenotypemedicine.anatomical_structuresubcutaneousFemaleBronchial HyperreactivityBALB/cAdjuvantInjections IntraperitonealOvalbuminInjections SubcutaneousImmunologyOriginal Articles:Experimental Models of Allergic Diseaseβ-galactosidaseSensitivity and Specificitycomplex mixturesBALB/cadjuvantAdjuvants ImmunologicAntigenmedicineAnimalsSkin TestsAsthmaAlumbusiness.industryanimal modelAllergensbeta-Galactosidasebiology.organism_classificationmedicine.diseaseAsthmabehaviourrespiratory tract diseasesMice Inbred C57BLDisease Models AnimalOvalbuminalumchemistryImmunologybiology.proteinbusinessClinical & Experimental Allergy
researchProduct

A Role for Leukocyte-Derived IL-1RA in DC Homeostasis Revealed by Increased Susceptibility of IL-1RA-Deficient Mice to Cutaneous Leishmaniasis

2011

Dendritic cell (DC)-derived IL-1α/β plays a critical role in the induction of T helper type 1 (Th1)-dependent immunity against Leishmania . DCs from susceptible BALB/c mice produce less IL-1α/β when compared with resistant C57BL/6 mice, contributing to aberrant Th2 development and ultimate death of infected mice. We have extended our studies of the role of IL-1 in leishmaniasis using IL-1RA -/- BALB/c mice that are characterized by upregulated IL-1 receptor signaling. Unexpectedly, infection of IL-1RA -/- mice led to significantly worsened disease outcome with larger lesions, dramatically higher parasite burdens, and decreased IFN-γ production by antigen-specific T cells. We determined that…

medicine.medical_treatmentLeishmaniasis CutaneousBone Marrow CellsDermatologyBiochemistryArticleImmunophenotypingMicePhagocytosisCutaneous leishmaniasisDownregulation and upregulationImmunitymedicineAnimalsLeishmania majorMolecular BiologyLeishmania majorMice Inbred BALB CbiologyLeishmaniasisDendritic CellsDendritic cellCell BiologyTh1 Cellsmedicine.diseasebiology.organism_classificationLeishmaniaInterleukin-12Mice Mutant StrainsInterleukin 1 Receptor Antagonist ProteinCytokineImmunologyDisease SusceptibilityInterleukin-1Journal of Investigative Dermatology
researchProduct

Ex vivoevidence for PGE2and LTB4involvement in cutaneous leishmaniasis: relation with infection status and cytokine production

1996

SUMMARYEx vivoculture of spleen cells from BALB/c mice infected with 2 × 106Leishmania major(L.major) promastigotes were cultured with ConcanavalinA (ConA) or leishmanial antigen (L. Ag) and tested for prostaglandin E2(PGE2) and for leukotriene B4(LTB4), in order to study their involvement in the evolution of cutaneous leishmaniasis and the connexion with lymphokine-mediated responses. The data were compared with those obtained in BALB/c mice protected againstL. majorby sublethal irradiation (550 rad; cured mice). In the unprotected BALB/c mice the levels of PGE2that were responsible for the depression of interferon-γ (IFN-γ) and tumour necrosis factor-α (TNFα) Th1-associated cytokines and …

medicine.medical_treatmentLeishmaniasis CutaneousInflammationLeukotriene B4DinoprostoneInterferon-gammaMiceTh2 CellsImmune systemCutaneous leishmaniasismedicineAnimalsLeishmania majorInterferon gammaCells CulturedLeishmania majorMice Inbred BALB CbiologyTumor Necrosis Factor-alphaTh1 Cellsbiology.organism_classificationmedicine.diseaseInfectious DiseasesCytokineImmunologyFemaleAnimal Science and ZoologyParasitologyTumor necrosis factor alphaInterleukin-4medicine.symptomSpleenWhole-Body IrradiationEx vivomedicine.drugParasitology
researchProduct

IL-1 signalling is dispensable for protective immunity in Leishmania-resistant mice

2010

Leishmaniasis is a parasitic disease affecting ∼12 million people. Control of infection (e.g. in C57BL/6 mice) results from IL-12-dependent production of IFNγ by Th1/Tc1 cells. In contrast, BALB/c mice succumb to infection because of preferential Th2-type cytokine induction. Infected dendritic cells (DC) represent important sources of IL-12. Genetically determined differences in DC IL-1α/β production contribute to disease outcome. Whereas the course of disease was not dramatically altered in IL-1RI(-/-) mice, local administration of IL-1α to infected C57BL/6 mice improved disease outcome. To definitively elucidate the involvement of IL-1 in immunity against leishmaniasis, we now utilized IL…

medicine.medical_treatmentLeishmaniasisDermatologyDendritic cellBiologymedicine.diseasebiology.organism_classificationLeishmaniaBiochemistryVaccinationCytokineCutaneous leishmaniasisImmunityImmunologymedicineLeishmania majorMolecular BiologyExperimental Dermatology
researchProduct

Immune Modulating Effects of NKT Cells in a Physiologically Low Dose Leishmania major Infection Model after αGalCer Analog PBS57 Stimulation

2014

Leishmaniasis is a parasitic infection affecting ∼12 million people worldwide, mostly in developing countries. Treatment options are limited and no effective vaccines exist to date. Natural Killer T (NKT) cells are a conserved innate-like lymphocyte population with immunomodulating effects in various settings. A number of reports state a role of NKT cells in different models of Leishmania infection. Here, we investigated the effect of NKT cells in a physiologically relevant, intradermal low dose infection model. After inoculation of 103 infectious-stage L. major, comparable numbers of skin-immigrating NKT cells in both susceptible BALB/c mice and resistant C57BL/6 mice were noted. Compared …

medicine.medical_treatmentLymphocyteMedizinPathogenesisNK cellsProtozoologyPathology and Laboratory MedicineCellular typesMedicine and Health SciencesLymphoid OrgansLeishmania majorImmune ResponseLeishmania majorSkinProtozoansMice Inbred BALB Ceducation.field_of_studybiologylcsh:Public aspects of medicineNatural killer T cellInfectious Diseasesmedicine.anatomical_structureCytokineMedical MicrobiologyHost-Pathogen InteractionsWhite blood cellsCytokinesAnatomyResearch ArticleCell biologyBlood cellslcsh:Arctic medicine. Tropical medicinelcsh:RC955-962Immune CellsImmunologyPopulationT cellsLeishmaniasis CutaneousGalactosylceramidesSpleenImmunopathologyMicrobiologyLymphatic SystemImmunomodulationImmune ActivationImmune systemImmunityMicrobial ControlmedicineAnimalsImmunologic FactorseducationImmunity to InfectionsMicrobial PathogensBiology and life sciencesImmunityOrganismsPublic Health Environmental and Occupational HealthImmunoregulationlcsh:RA1-1270Molecular Developmentbiology.organism_classificationAcquired Immune SystemParasitic ProtozoansMice Inbred C57BLDisease Models AnimalAnimal cellsImmune SystemImmunologyNatural Killer T-CellsClinical ImmunologyParasitologyDevelopmental Biology
researchProduct

Continuous subcutaneous Insulin infusion leads to immediate, table, and long-term changes in metabolic control

2008

Background:  Evaluations of continuous subcutaneous insulin infusion (CSII) usually focus on one pre- and one post-CSII measurement to assess metabolic therapy outcome. Aim:  Extending this research, the aim of the present study was to provide a more fine-grained analysis of achieved glycaemic control. Methods:  In 52 patients with type 1 diabetes (mean age of 37.85 years at CSII begin; s.d. ± 12.41), haemoglobin A1c (HbA1c) levels were assessed every 3 months over a period of 5 years (1 year before and 4 years after the introduction of CSII). Mixed models were utilized to describe changes in glycaemic control. Results:  The pre–post course showed that already in the first quarter, a statis…

mixed modelsAdultBlood GlucoseMalemedicine.medical_specialtyPediatricstype 1 diabetesEndocrinology Diabetes and MetabolismModels BiologicalDrug Administration ScheduleTimeHba1c levelEndocrinologyDiabetes mellitusInternal Medicinemedicinefollow upHumansHypoglycemic AgentsInsulinAge of OnsetGlycated HemoglobinType 1 diabetesHaemoglobin A1cbusiness.industry10093 Institute of PsychologyCSIIMean ageInfusion Pumps ImplantableMiddle AgedPrognosismedicine.diseaseSubcutaneous insulinSurgery1310 Endocrinologylong-term changes2712 Endocrinology Diabetes and MetabolismDiabetes Mellitus Type 1Treatment Outcome2724 Internal MedicineMetabolic control analysisFemalebusiness150 PsychologyFollow-Up StudiesMetabolic therapy
researchProduct

Galvenie akūta retrovirāla sindroma simptomi, ādas un gļotādas izpausmes HIV pozitīviem pacientiem korelācijā ar imūnsupresiju un CD4 T šūnu skaitu L…

2018

Ievads: HIV ir viens no visplašāk izplatījiem vīrusu patogēniem pasaulē. Slimības akūtās fāzes izpausmes ir grūti pamanāmas. Pašreizējie pētījumi liecina, ka svaigi inficēti pacienti gūst priekšrocības no agrīnas diagnostikas attiecībā uz slimības gaitu un dzīves pagarināšanu. Tā kā ādas izpausmes ir vienas no visbiežāk sastopamajām, ir svarīgi tās kritiski izvērtēt gadījumā, ja tās parādās citādi veselīga izskata pacientam. Mērķi: Pētījuma mērķis ir analizēt akūtā retrovīrusu sindroma (ARS) galvenos simptomus, lai veicinātu diagnostiku jau akūtas HIV infekcijas laikā, un noteikt, vai pastāv cieša saikne starp noteiktu ādas bojājumu rašanos un CD4 T šūnu skaitu. Materiāli un metodes: pētīju…

mucocutaneous skin lesionsakūtas HIV infekcijas simptomiHIVacute retroviral syndromeCD4Medicīna
researchProduct

Rates of Upper Facet Joint Violation in Minimally Invasive Percutaneous and Open Instrumentation: A Comparative Cohort Study of Different Insertion T…

2017

Background Minimally invasive pedicle screw placement may have a higher incidence of violation of the superior cephalad unfused facet joint. Study Aims We investigated the incidence and risk factors of upper facet joint violation in percutaneous robot-assisted instrumentation versus percutaneous fluoroscopy-guided and open transpedicular instrumentation. Methods A retrospective study including all consecutive patients who underwent lumbar instrumentation, fusion, and decompression for spondylolisthetic stenosis and degenerative disk disease was conducted between January 2012 and January 2016. All operations were performed by the same surgeon; the patients were divided into three groups acc…

musculoskeletal diseasesAdultMalemedicine.medical_specialtyPercutaneousDecompressionIntervertebral Disc DegenerationSurgical planningNeurosurgical ProceduresZygapophyseal JointFacet joint03 medical and health sciences0302 clinical medicineLumbarSpinal StenosisPedicle ScrewsRisk FactorsmedicineHumansInstrumentation (computer programming)AgedRetrospective Studies030222 orthopedicsLumbar Vertebraebusiness.industryRetrospective cohort studyMiddle Agedmusculoskeletal systemmedicine.diseaseSurgeryStenosismedicine.anatomical_structureSpinal FusionTreatment OutcomeSurgeryFemaleNeurology (clinical)business030217 neurology & neurosurgeryJournal of neurological surgery. Part A, Central European neurosurgery
researchProduct